IN8bio Inc (INAB) Stock Price, Quote, News & History

INABNASDAQ
$1.33
-0.05-3.62%
At close: Jul 17, 5:00 PM EST
$1.31
-0.02-1.50%
After Hours: 5:34 PM EST
Loading...

Key Statistics

Open
$1.35
Close
$1.33
Volume / Avg.
65.50K / 59.59K
Day Range
$1.31 - $1.37
52 Wk Range
1.17 - 2.73
Market Cap
$12.56M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
0.41%
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-14.54M
Investing Cash Flow (TTM)
-9.00K
Financing Cash Flow (TTM)
24.55M
Free Cash Flow (TTM)
-14.55M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
10.00M

Analyst Trends and Forecast

1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$6.69M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.60
Earnings Yield % (TTM)
-182.73%
Earnings Yield % (FWD)
-160.43%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.31

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$575.00K
Total Cash
$21.94M
Debt to Equity
0.10
Issuance of Debt (TTM)
-$575.00K
Repayment of Debt (TTM)
-$575.00K

Key Statistics

Open
$1.35
Close
$1.33
Volume / Avg.
65.50K / 59.59K
Day Range
$1.31 - $1.37
52 Wk Range
1.17 - 2.73
Market Cap
$12.56M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
0.41%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy IN8bio (INAB) stock?

A

You can purchase shares of IN8bio (NASDAQ:INAB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are IN8bio (INAB) competitors?

A

There are no as such competitors for IN8bio.

Q

What is the forecast, or price target, for IN8bio (INAB) stock?

A

IN8bio has a consensus price target of $4.92.

Q

What is the current price for IN8bio (INAB)?

A

The stock price for IN8bio (NASDAQ: INAB) is $1.31 last updated July 17, 2026 at 5:34 PM EDT.

Q

Does IN8bio (INAB) pay a dividend?

A

There are no upcoming dividends for IN8bio.

Q

When is IN8bio (NASDAQ:INAB) reporting earnings?

A

IN8bio does not have any upcoming earnings scheduled.

Q

Is IN8bio (INAB) going to split?

A

There is no upcoming split for IN8bio.

Q

What sector and industry does IN8bio (INAB) operate in?

A

IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.